The 'Dispatched' Podcast

By: Daily Dispatch
  • Summary

  • BioPharmaDispatch - discussing the issues impacting the Australian biopharmaceutical and life sciences sectors with Paul Cross and Felicity McNeill.

    © 2024 The 'Dispatched' Podcast
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • The 'Week in Review' - 1 November September
    Nov 1 2024

    It's another week of debate over PBS deferrals. Unfortunately, there appears to be an effort to limit public discussion. Given the obvious risk to patients and the implications for the access agenda, which is flailing against the backdrop of deferrals, how does that make sense? It also stands in stark contrast to when cost recovery was introduced.

    Show more Show less
    27 mins
  • The 'Week in Review' Podcast - 25 October
    Oct 24 2024

    The health department calls them 'holdover' submissions, but they're deferrals. Its strange language does not change the fact that this situation, decided without consultation, could have negative and long-lasting consequences for the world's second-oldest public health program and, more importantly, patients.

    Show more Show less
    45 mins
  • The 'Dispatched' Podcast - Special Edition
    Oct 22 2024

    A special edition focused on the disappointing and unacceptable outcome on the proposed simplified and faster process for immunotherapies. The institution has revealed a disturbing attitude to patients shrouded in an ability to deliver change.

    Show more Show less
    37 mins

What listeners say about The 'Dispatched' Podcast

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.